Antibodies for biodefense

Botulinum Neurotoxin Vaccines:  Past history and recent developments

(2014) Janice M. Rusnak et al.   Human vaccines & immunotherapeutics

Preserving the Lifesaving Power of Antimicrobial Agents

(2011) James M. Hughes   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Laboratory Animal Models for Brucellosis Research

(2011) Teane M. A. Silva et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

IBC's 21stAnnual Antibody Engineering and 8thAnnual Antibody Therapeutics International Conferences and 2010 Annual Meeting of The Antibody Society

(2011) Samantha O Arnett et al.   mAbs

Enhanced Neutralization Potency of Botulinum Neurotoxin Antibodies Using a Red Blood Cell-Targeting Fusion Protein

(2011) Sharad P. Adekar et al.   PLoS One

Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection

(2011) Ann R. Hunt et al.   VIROLOGY

Molecular Insights intoBurkholderia pseudomalleiandBurkholderia malleiPathogenesis

(2010) Edouard E. Galyov et al.   Annual Review of Microbiology

Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model

(2010) Megan M McCausland et al.   ANTIVIRAL THERAPY

Adverse Events Following Smallpox Vaccination With ACAM2000 in a Military Population

(2010) Thomas M. Beachkofsky et al.   ARCHIVES OF DERMATOLOGY

Oral Vaccine Formulations Stimulate Mucosal and Systemic Antibody Responses against Staphylococcal Enterotoxin B in a Piglet Model

(2010) T. K. Inskeep et al.   Clinical and Vaccine Immunology

Potent Neutralization of Staphylococcal Enterotoxin B by Synergistic Action of Chimeric Antibodies

(2010) M. E. Tilahun et al.   INFECTION AND IMMUNITY

Update on brucellosis: therapeutic challenges

(2010) Javier Solera   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Probabilities of success for antibody therapeutics

(2010) Janice M. Reichert   mAbs

Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1

(2010) Mei-Yun Zhang et al.   mAbs

Development trends for human monoclonal antibody therapeutics

(2010) Aaron L. Nelson et al.   NATURE REVIEWS DRUG DISCOVERY

Immunoproteomics Analysis of the Murine Antibody Response to Vaccination with an Improved Francisella tularensis Live Vaccine Strain (LVS)

(2010) Susan M. Twine et al.   PLoS One

Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model

(2010) Xiaodong Xiao et al.   PLoS One

Inhibition of Toxic Shock by Human Monoclonal Antibodies against Staphylococcal Enterotoxin B

(2010) Eileen A. Larkin et al.   PLoS One

Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule

(2010) Z. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating

(2010) J. Lou et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin

(2010) C. Garcia-Rodriguez et al.   PROTEIN ENGINEERING DESIGN & SELECTION

A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus

(2010) Wei-Gang Hu et al.   VACCINE

REVIEW PAPER

(2010) K. E. Steele et al.   VETERINARY PATHOLOGY

Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms

(2010) Devon J. Shedlock et al.   VIROLOGY

Treatment of respiratory syncytial virus with palivizumab: a systematic review

(2010) Jia Hu et al.   World Journal of Pediatrics

ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile

(2010) Aysegul Nalca et al.   Drug Design Development and Therapy

The First Human Epitope Map of the Alphaviral E1 and E2 Proteins Reveals a New E2 Epitope with Significant Virus Neutralizing Activity

(2010) Ann R. Hunt et al.   PLoS Neglected Tropical Diseases

Safety and Pharmacokinetics of Chimeric Anti-Shiga Toxin 1 and Anti-Shiga Toxin 2 Monoclonal Antibodies in Healthy Volunteers

(2009) M. Bitzan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity

(2009) Thibaut Pelat et al.   BMC BIOTECHNOLOGY

The public health implications of melioidosis

(2009) Timothy J.J. Inglis et al.   Brazilian Journal of Infectious Diseases

Dual-Function Antibodies to Yersinia pestis LcrV Required for Pulmonary Clearance of Plague

(2009) N. A. Eisele et al.   Clinical and Vaccine Immunology

Francisella tularensis Infection-Derived Monoclonal Antibodies Provide Detection, Protection, and Therapy

(2009) A. G. Savitt et al.   Clinical and Vaccine Immunology

Broad recognition of ricin toxins prepared from a range ofRicinuscultivars using immunochromatographic tests

(2009) Philippe Thullier et al.   CLINICAL TOXICOLOGY

Novel Chimpanzee/Human Monoclonal Antibodies That Neutralize Anthrax Lethal Factor, and Evidence for Possible Synergy with Anti-Protective Antigen Antibody

(2009) Z. Chen et al.   INFECTION AND IMMUNITY

Monoclonal Antibody 11E10, Which Neutralizes Shiga Toxin Type 2 (Stx2), Recognizes Three Regions on the Stx2 A Subunit, Blocks the Enzymatic Action of the Toxin In Vitro, and Alters the Overall Cellular Distribution of the Toxin

(2009) M. J. Smith et al.   INFECTION AND IMMUNITY

A Novel Role for Plasmin-Mediated Degradation of Opsonizing Antibody in the Evasion of Host Immunity by Virulent, but Not Attenuated, Francisella tularensis

(2009) D. D. Crane et al.   JOURNAL OF IMMUNOLOGY

Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes

(2009) M. N. Dharmasena et al.   MICROBIOLOGY-SGM

Raxibacumab for the Treatment of Inhalational Anthrax

(2009) Thi-Sau Migone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Advances in the development of next-generation anthrax vaccines

(2009) Arthur M. Friedlander et al.   VACCINE

Amino acid residues 196–225 of LcrV represent a plague protective epitope

(2009) Lauriane E. Quenee et al.   VACCINE

Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV)

(2008) Martina Kirsch et al.   BMC BIOTECHNOLOGY

Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxins

(2008) Sharad P. Adekar et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57Bl/6 mice

(2008) G.-Y. G. Tan et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis

(2008) J. Wayne Conlan et al.   MOLECULAR IMMUNOLOGY

Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain

(2008) Sharad P. Adekar et al.   PLoS One

Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: A new mouse model

(2008) Louis M. Huzella et al.   RESEARCH IN VETERINARY SCIENCE